Pyrimidine derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 21, 2005
Grant Date -
Nov 20, 2003
app pub date -
Jul 6, 2001
filing date -
Jul 11, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Compounds of formula (I), wherein R1, p, R2, q, R3 and R4 are defined within, and a pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-blooded animal, such as man ##STR1##
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully